Product Information
METHAZOLAMIDE 25 MG TABLET is a generic product labeled by Bausch & Lomb Incorporated, priced at $0.7841 per EA under NDC 24208002210. Its NADAC has been published 138 times since Nov 8, 2023.
Strength
25 mg/1
Manufacturer
Bausch & Lomb IncorporatedNDC
24208002210
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METHAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207438On Market Since
10/2/2020
Price Statistics
The NADAC for METHAZOLAMIDE 25 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 33.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7841 per EA |
|---|---|
| All-time high | $1.1856 (Mar 13, 2024) |
| All-time low | $0.7422 (May 21, 2025) |
| 52-week high | $1.0036 |
| 52-week low | $0.7458 |
| Median price | $0.8523 |
| Average price | $0.8981 |
| Largest weekly change | -21.1% (Apr 17, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METHAZOLAMIDE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHAZOLAMIDE 25 MG TABLET, manufactured by Bausch & Lomb Incorporated, is $0.7841 per EA (NDC 24208002210), effective Jun 24, 2026.
How has the price of METHAZOLAMIDE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHAZOLAMIDE 25 MG TABLET has declined 33.9%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for METHAZOLAMIDE 25 MG TABLET?
Since Nov 8, 2023, the NADAC for METHAZOLAMIDE 25 MG TABLET has ranged from a low of $0.7422 (May 21, 2025) to a high of $1.1856 (Mar 13, 2024), with a median of $0.8523 per EA.
Are there cheaper alternatives to METHAZOLAMIDE 25 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as METHAZOLAMIDE 25 MG TABLET, but none are currently priced below it.
Who manufactures METHAZOLAMIDE 25 MG TABLET?
METHAZOLAMIDE 25 MG TABLET (NDC 24208002210) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification